Arbutus Biopharma Statistics
Total Valuation
ABUS has a market cap or net worth of $590.68 million. The enterprise value is $463.13 million.
Market Cap | 590.68M |
Enterprise Value | 463.13M |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, before market open.
Earnings Date | Aug 1, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ABUS has 188.72 million shares outstanding. The number of shares has increased by 8.65% in one year.
Shares Outstanding | 188.72M |
Shares Change (YoY) | +8.65% |
Shares Change (QoQ) | +4.18% |
Owned by Insiders (%) | 22.29% |
Owned by Institutions (%) | 44.30% |
Float | 135.49M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 45.49 |
Forward PS | 86.03 |
PB Ratio | 5.15 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 35.66 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.70, with a Debt / Equity ratio of 0.01.
Current Ratio | 6.70 |
Quick Ratio | 6.47 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -242.89 |
Financial Efficiency
Return on equity (ROE) is -62.70% and return on invested capital (ROIC) is -68.84%.
Return on Equity (ROE) | -62.70% |
Return on Assets (ROA) | -47.20% |
Return on Capital (ROIC) | -68.84% |
Revenue Per Employee | $177,890 |
Profits Per Employee | -$1.02M |
Employee Count | 73 |
Asset Turnover | 0.08 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.89% in the last 52 weeks. The beta is 1.98, so ABUS's price volatility has been higher than the market average.
Beta (5Y) | 1.98 |
52-Week Price Change | +37.89% |
50-Day Moving Average | 3.04 |
200-Day Moving Average | 2.49 |
Relative Strength Index (RSI) | 51.34 |
Average Volume (20 Days) | 1,189,696 |
Short Selling Information
The latest short interest is 5.37 million, so 2.85% of the outstanding shares have been sold short.
Short Interest | 5.37M |
Short Previous Month | 5.03M |
Short % of Shares Out | 2.85% |
Short % of Float | 3.96% |
Short Ratio (days to cover) | 5.13 |
Income Statement
In the last 12 months, ABUS had revenue of $12.99 million and -$74.39 million in losses. Loss per share was -$0.44.
Revenue | 12.99M |
Gross Profit | 12.99M |
Operating Income | -80.08M |
Pretax Income | -74.39M |
Net Income | -74.39M |
EBITDA | -72.66M |
EBIT | -74.08M |
Loss Per Share | -$0.44 |
Balance Sheet
The company has $129.24 million in cash and $1.68 million in debt, giving a net cash position of $127.56 million or $0.68 per share.
Cash & Cash Equivalents | 129.24M |
Total Debt | 1.68M |
Net Cash | 127.56M |
Net Cash Per Share | $0.68 |
Equity (Book Value) | 114.64M |
Book Value Per Share | 0.61 |
Working Capital | 115.58M |
Cash Flow
In the last 12 months, operating cash flow was -$77.93 million and capital expenditures -$966,000, giving a free cash flow of -$78.90 million.
Operating Cash Flow | -77.93M |
Capital Expenditures | -966,000 |
Free Cash Flow | -78.90M |
FCF Per Share | -$0.45 |
Margins
Gross margin is 100.00%, with operating and profit margins of -616.64% and -572.81%.
Gross Margin | 100.00% |
Operating Margin | -616.64% |
Pretax Margin | -572.81% |
Profit Margin | -572.81% |
EBITDA Margin | -559.49% |
EBIT Margin | -570.46% |
FCF Margin | -607.55% |
Dividends & Yields
ABUS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -8.65% |
Shareholder Yield | -8.65% |
Earnings Yield | -12.59% |
FCF Yield | -13.36% |
Analyst Forecast
The average price target for ABUS is $4.33, which is 38.34% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.33 |
Price Target Difference | 38.34% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 26.07% |
EPS Growth Forecast (5Y) | -13.37% |
Stock Splits
The last stock split was on November 4, 2010. It was a reverse split with a ratio of 1:5.
Last Split Date | Nov 4, 2010 |
Split Type | Reverse |
Split Ratio | 1:5 |
Scores
ABUS has an Altman Z-Score of -2.74 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -2.74 |
Piotroski F-Score | 2 |